Contact this trialFirst, we need to learn more about you.
Saltikva for Pancreatic Cancer
Recruiting1 awardPhase 2
Montreal, Quebec
This trial tests Saltikva, a safe, modified Salmonella bacteria that delivers an immune booster directly to tumors, in patients with advanced pancreatic cancer. The goal is to see if adding Saltikva to standard chemotherapy can help patients live longer and slow down the progression of their disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service